Evidence map›Paper›PMID 30543660›Full record

ArticlePloS one2018

LbL-assembled gentamicin delivery system for PMMA bone cements to prolong antimicrobial activity.

Yazan Al Thaher, Lirong Yang, Steve A Jones, Stefano Perni, Polina Prokopovich

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Implantable biomedical materials for treatment of bone infection.Frontiers in bioengineering and biotechnology · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yazan Al ThaherSchool of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, United Kingdom.
Lirong YangSchool of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, United Kingdom.
Steve A JonesUniversity Hospital Llandough, Cardiff & Vale University Health Board, Vale of Glamorgan, Wales, United Kingdom.
Stefano PerniSchool of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, United Kingdom.
Polina ProkopovichSchool of Pharmacy and Pharmaceutical Science, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-5700-9570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAntibiotic-loaded poly(methyl methacrylate) bone cements (ALBCs) are widely used in total joint replacement (TJR), for local delivery of antibiotics to provide prophylaxis against prosthetic joint infections (PJI). One of the shortcomings of the current generation of ALBCs is that the antibiotic release profile is characterized by a burst over the first few hours followed by a sharp decrease in rate for the following several days (often below minimum inhibitory concentration (MIC)), and, finally, exhaustion (after, typically, ~ 20 d). This profile means that the ALBCs provide only short-term antimicrobial action against bacterial strains involved PJI. RATIONALE: The purpose of the present study was to develop an improved antibiotic delivery system for an ALBC. This system involved using a layer-by-layer technique to load the antibiotic (gentamicin sulphate) (GEN) on silica nanoparticles, which are then blended with the powder of the cement. Then, the powder was mixed with the liquid of the cement (NP-GEN cement). For controls, two GEN-loaded brands were used (Cemex Genta and Palacos R+G). Gentamicin release and a host of other relevant properties were determined for all the cements studied.

resultsCompared to control cement specimens, improved GEN release, longer antimicrobial activity (against clinically-relevant bacterial strains), and comparable setting time, cytocompatibility, compressive strength (both prior to and after aging in PBS at 37 oC for 30 d), 4-point bend strength and modulus, fracture toughness, and PBS uptake.

conclusionsNP-GEN cement may have a role in preventing or treating PJI.

Indexed as

Bone CementsDrug Delivery SystemsAnti-Infective AgentsCell LineCell SurvivalCompressive StrengthGentamicinsHumansMaterials TestingMicrobial Sensitivity TestsNanoparticlesNanotechnologyOsteoblastsPolymethyl MethacrylateProsthesis-Related InfectionsRheologyAnti-Infective AgentsBone CementsGentamicinsPolymethyl MethacrylateSilicon Dioxide

Identifiers

PMID30543660
PMCPMC6292632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.